Soliton Provides Special 510(k) and Commercialization Update
HOUSTON, April 15, 2021 /PRNewswire/ — Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology, today announced that the U.S. Food and Drug Administration (“FDA”) has accepted its special 510(k) application…
Comments Off on Soliton Provides Special 510(k) and Commercialization Update